About
Pepgen Ltd (NASDAQ:PEPG) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 30 2026
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
Mar 4 2026
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
Mar 4 2026
PepGen Announces Regulatory Updates on FREEDOM2
Mar 3 2026
PepGen to Participate in the Leerink Global Healthcare Conference
Dec 9 2025
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
Financials
Revenue
$0
Market Cap
$125.79 M
EPS
-2.12
Translate